RxDoctor Payments Data

Ivan Rubiano, DPM

Foot & Ankle Surgery · Roanoke, VANPI 1689020703

Payments from drug & device makers

$5,704in general payments, 2019–2025

Across 110 payments — averaging $51.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • Stryker$871
  • Medical Device Business Services, Inc.$838
  • RTI Surgical, Inc$500
  • Nevro Corp.$235
  • Zimmer Biomet$170
  • plus $2K from 24 others
$173,745in research payments, 2019–2025

Across 17 payments — averaging $10,220 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Polarityte, Inc.$174K

What the payments were for

  • Consulting fees$5009%
  • Travel & lodging$79414%
  • Food & beverage$4,36376%
  • Education$70%
  • Entertainment$401%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,704 in reported general payments places this provider in the 60th percentile of 260 foot & ankle surgery providers in Virginia.

See all foot & ankle surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$357,017
Medicare patients
551
Services billed
2,245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole167$4,047
Gabapentin56$561
Doxycycline Hyclate48$460
Diclofenac Sodium12$377
Methylprednisolone35$188
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$150
Meloxicam60$149
Zonisamide11$144
Cephalexin11$132
Mupirocin13$70
Ciprofloxacin Hcl16$64
Tramadol Hcl11$46

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →